M&T Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11,415
| Closed | -$2.1M | – | 1658 |
|
|
2021
Q2 | $2.1M | Sell |
11,415
-972
| -8% | -$167K | 0.01% | 550 |
|
|
2021
Q1 | $1.89M | Sell |
12,387
-1,404
| -10% | -$217K | 0.01% | 575 |
|
|
2020
Q4 | $2.15M | Sell |
13,791
-322
| -2% | -$41.4K | 0.01% | 556 |
|
|
2020
Q3 | $1.61M | Sell |
14,113
-105
| -0.7% | -$11.3K | 0.01% | 579 |
|
|
2020
Q2 | $1.59M | Buy |
+14,218
| New | +$1.51M | 0.01% | 571 |
|
|
2020
Q1 | – | Sell |
-15,412
| Closed | -$1.67M | – | 1727 |
|
|
2019
Q4 | $1.67M | Sell |
15,412
-733
| -5% | -$78.4K | 0.01% | 489 |
|
|
2019
Q3 | $1.58M | Sell |
16,145
-356
| -2% | -$40.1K | 0.01% | 582 |
|
|
2019
Q2 | $2.16M | Sell |
16,501
-270
| -2% | -$34.8K | 0.01% | 502 |
|
|
2019
Q1 | $2.27M | Sell |
16,771
-3,021
| -15% | -$376K | 0.01% | 493 |
|
|
2018
Q4 | $1.93M | Buy |
19,792
+489
| +3% | +$57.8K | 0.01% | 505 |
|
|
2018
Q3 | $2.68M | Sell |
19,303
-12,669
| -40% | -$1.59M | 0.01% | 471 |
|
|
2018
Q2 | $3.97M | Buy |
31,972
+819
| +3% | +$95.7K | 0.02% | 386 |
|
|
2018
Q1 | $3.47M | Sell |
31,153
-1,743
| -5% | -$208K | 0.02% | 408 |
|
|
2017
Q4 | $3.94M | Sell |
32,896
-4,796
| -13% | -$584K | 0.02% | 386 |
|
|
2017
Q3 | $5.29M | Buy |
37,692
+5,407
| +17% | +$735K | 0.03% | 335 |
|
|
2017
Q2 | $3.93M | Buy |
32,285
+9,080
| +39% | +$1.06M | 0.02% | 374 |
|
|
2017
Q1 | $2.81M | Sell |
23,205
-3,955
| -15% | -$510K | 0.02% | 450 |
|
|
2016
Q4 | $3.32M | Sell |
27,160
-747
| -3% | -$91.4K | 0.02% | 408 |
|
|
2016
Q3 | $3.42M | Sell |
27,907
-1,084
| -4% | -$140K | 0.02% | 396 |
|
|
2016
Q2 | $3.38M | Sell |
28,991
-2,154
| -7% | -$306K | 0.02% | 399 |
|
|
2016
Q1 | $4.33M | Sell |
31,145
-1,024
| -3% | -$150K | 0.03% | 355 |
|
|
2015
Q4 | $6.13M | Sell |
32,169
-3,387
| -10% | -$592K | 0.04% | 294 |
|
|
2015
Q3 | $5.56M | Buy |
35,556
+4,562
| +15% | +$832K | 0.04% | 310 |
|
|
2015
Q2 | $5.6M | Sell |
30,994
-960
| -3% | -$166K | 0.03% | 327 |
|
|
2015
Q1 | $5.54M | Sell |
31,954
-2,941
| -8% | -$532K | 0.03% | 346 |
|
|
2014
Q4 | $6.46M | Buy |
34,895
+685
| +2% | +$127K | 0.04% | 318 |
|
|
2014
Q3 | $5.67M | Buy |
34,210
+25,210
| +280% | +$4.14M | 0.04% | 346 |
|
|
2014
Q2 | $1.41M | Sell |
9,000
-836
| -8% | -$132K | 0.06% | 226 |
|
|
2014
Q1 | $1.5M | Sell |
9,836
-2,108
| -18% | -$335K | 0.06% | 206 |
|
|
2013
Q4 | $1.59M | Sell |
11,944
-1,568
| -12% | -$188K | 0.07% | 200 |
|
|
2013
Q3 | $1.57M | Sell |
13,512
-3,618
| -21% | -$397K | 0.07% | 182 |
|
|
2013
Q2 | $1.58M | Buy |
+17,130
| New | +$1.65M | 0.08% | 184 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM